Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells $159,313.80 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 46,857 shares of the company’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the sale, the chief executive officer now directly owns 418,637 shares in the company, valued at $1,423,365.80. This represents a 10.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Amit Gupta also recently made the following trade(s):

• On Friday, January 24th, Amit Gupta sold 15,160 shares of Cardlytics stock. The stock was sold at an average price of $3.92, for a total value of $59,427.20.
• On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The stock was sold at an average price of $3.67, for a total value of $21,887.88.

Cardlytics Stock Down 9.1 %

Shares of CDLX opened at $2.69 on Friday. The business’s fifty day moving average price is $3.42 and its two-hundred day moving average price is $3.69. The firm has a market capitalization of $136.71 million, a price-to-earnings ratio of -0.44 and a beta of 1.54. Cardlytics, Inc. has a 52 week low of $2.67 and a 52 week high of $20.52. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18.

Hedge Funds Weigh In On Cardlytics

Several large investors have recently made changes to their positions in CDLX. Two Sigma Advisers LP raised its holdings in Cardlytics by 44.1% during the 4th quarter. Two Sigma Advisers LP now owns 36,900 shares of the company’s stock worth $137,000 after purchasing an additional 11,300 shares during the last quarter. Two Sigma Investments LP grew its position in shares of Cardlytics by 12.5% during the 4th quarter. Two Sigma Investments LP now owns 94,901 shares of the company’s stock worth $352,000 after buying an additional 10,508 shares during the period. ProShare Advisors LLC bought a new stake in shares of Cardlytics during the fourth quarter worth approximately $43,000. Millennium Management LLC bought a new stake in shares of Cardlytics during the fourth quarter worth approximately $535,000. Finally, D. E. Shaw & Co. Inc. lifted its holdings in Cardlytics by 97.4% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,131,505 shares of the company’s stock valued at $4,198,000 after buying an additional 558,235 shares during the period. Institutional investors and hedge funds own 68.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on CDLX. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $6.92.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.